166 related articles for article (PubMed ID: 23435084)
1. Hyperimmune bovine colostrum for treatment of GI infections: a review and update on Clostridium difficile.
Steele J; Sponseller J; Schmidt D; Cohen O; Tzipori S
Hum Vaccin Immunother; 2013 Jul; 9(7):1565-8. PubMed ID: 23435084
[TBL] [Abstract][Full Text] [Related]
2. Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection.
Sponseller JK; Steele JA; Schmidt DJ; Kim HB; Beamer G; Sun X; Tzipori S
J Infect Dis; 2015 Apr; 211(8):1334-41. PubMed ID: 25381448
[TBL] [Abstract][Full Text] [Related]
3. Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease.
Steele J; Mukherjee J; Parry N; Tzipori S
J Infect Dis; 2013 Jan; 207(2):323-30. PubMed ID: 23125448
[TBL] [Abstract][Full Text] [Related]
4. Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products.
Sears KT; Tennant SM; Reymann MK; Simon R; Konstantopoulos N; Blackwelder WC; Barry EM; Pasetti MF
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637804
[TBL] [Abstract][Full Text] [Related]
5. The roles of toxin A and toxin B in Clostridium difficile infection: insights from the gnotobiotic piglet model.
Steele J; Parry N; Tzipori S
Gut Microbes; 2014; 5(1):53-7. PubMed ID: 24394234
[TBL] [Abstract][Full Text] [Related]
6. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.
Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY
BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596
[TBL] [Abstract][Full Text] [Related]
8. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.
Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H
Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245
[TBL] [Abstract][Full Text] [Related]
9. Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model.
Günaydın G; Zhang R; Hammarström L; Marcotte H
Vaccine; 2014 Jan; 32(4):470-7. PubMed ID: 24291196
[TBL] [Abstract][Full Text] [Related]
10. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.
Yang Z; Schmidt D; Liu W; Li S; Shi L; Sheng J; Chen K; Yu H; Tremblay JM; Chen X; Piepenbrink KH; Sundberg EJ; Kelly CP; Bai G; Shoemaker CB; Feng H
J Infect Dis; 2014 Sep; 210(6):964-72. PubMed ID: 24683195
[TBL] [Abstract][Full Text] [Related]
11. Novel Chimeric Protein Vaccines Against
Wang S; Wang Y; Cai Y; Kelly CP; Sun X
Front Immunol; 2018; 9():2440. PubMed ID: 30405630
[No Abstract] [Full Text] [Related]
12. Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives.
Hussack G; Tanha J
Toxins (Basel); 2010 May; 2(5):998-1018. PubMed ID: 22069622
[TBL] [Abstract][Full Text] [Related]
13. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL
PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843
[TBL] [Abstract][Full Text] [Related]
14. Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B.
Permpoonpattana P; Hong HA; Phetcharaburanin J; Huang JM; Cook J; Fairweather NF; Cutting SM
Infect Immun; 2011 Jun; 79(6):2295-302. PubMed ID: 21482682
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity.
Romano MR; Leuzzi R; Cappelletti E; Tontini M; Nilo A; Proietti D; Berti F; Costantino P; Adamo R; Scarselli M
Toxins (Basel); 2014 Apr; 6(4):1385-96. PubMed ID: 24759173
[TBL] [Abstract][Full Text] [Related]
16. Mouse relapse model of Clostridium difficile infection.
Sun X; Wang H; Zhang Y; Chen K; Davis B; Feng H
Infect Immun; 2011 Jul; 79(7):2856-64. PubMed ID: 21576341
[TBL] [Abstract][Full Text] [Related]
17. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate.
Lyerly DM; Bostwick EF; Binion SB; Wilkins TD
Infect Immun; 1991 Jun; 59(6):2215-8. PubMed ID: 2037383
[TBL] [Abstract][Full Text] [Related]
18. Immunisation of mares with binding domains of toxins A and B of Clostridium difficile elicits serum and colostral antibodies that block toxin binding.
Artiushin S; Timoney JF; Fettinger M; Fallon L; Rathgeber R
Equine Vet J; 2013 Jul; 45(4):476-80. PubMed ID: 23206274
[TBL] [Abstract][Full Text] [Related]
19. Bioactivity and efficacy of a hyperimmune bovine colostrum product- Travelan, against shigellosis in a non-Human primate model (Macaca mulatta).
Islam D; Ruamsap N; Imerbsin R; Khanijou P; Gonwong S; Wegner MD; McVeigh A; Poly FM; Crawford JM; Swierczewski BE; Kaminski RW; Laird RM
PLoS One; 2023; 18(12):e0294021. PubMed ID: 38091314
[TBL] [Abstract][Full Text] [Related]
20. Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model.
Heidebrecht HJ; Weiss WJ; Pulse M; Lange A; Gisch K; Kliem H; Mann S; Pfaffl MW; Kulozik U; von Eichel-Streiber C
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30736358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
